Search Results
Sort by:
Filter 0
Sort by
18 April 2023 - O1136
All-cause and attributable mortality in invasive candidiasis and/or Candidaemia with rezafungin and caspofungin treatment: outcomes from the ReSTORE trial
16 April 2023 - E0592
Outcomes of oral ibrexafungerp in subjects with urinary tract infections from two phase 3 open-label Studies: difficult-to-treat invasive fungal infections (FURI) and infections with Candida auris (CARES)
16 April 2023 - P2055
A novel protocol design to study the efficacy and safety of oral ibrexafungerp as step-down therapy following intravenous (IV) echinocandin for the treatment of invasive candidiasis (MARIO): developing a paradigm shift to IV and oral anti-cell wall therap
16 April 2023 - P2048
Rezafungin and caspofungin treatment response in candidaemia/invasive candidiasis by baseline Candida species: analysis of pooled Phase 2 and Phase 3 results
16 April 2023 - E0593
Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with Candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and Phase 3 data
16 April 2023 - P2063
Treatment outcomes in candidaemia and/or invasive candidiasis among patients receiving rezafungin or caspofungin while the fungal culture was still positive
16 April 2023 - P2061
Safety outcomes with rezafungin and caspofungin in the treatment of candidaemia and/or invasive candidiasis: phase 3 data from the ReSTORE trial
15 April 2023 - P0287
Activity of new antibiotics against non-carbapenamase producing carbapenem-altered susceptibility Pseudomonas aeruginosa
25 April 2022 - B0034
Patient-level meta-analysis of efficacy and safety from STRIVE and ReSTORE: randomised, double-blinded, multi-centre phase II and phase III trials of rezafungin in the treatment of candidaemia and/or invasive candidiasis
23 April 2022 - L0244
ReSTORE: efficacy and safety results of the phase III, noninferiority trial of rezafungin in the treatment of candidaemia and/or invasive candidiasis
16 April 2019 - L0010
Favorable Response to Oral Ibrexafungerp (formerly SCY-078) in Patients with Refractory Fungal Diseases, Interim Analysis by Pathogen from a Phase 3 Open-label Study (FURI)
13 April 2019 - P0125
Use of ibrexafungerp (formerly SCY-078) to treat severe azole-refractory oesophageal candidiasis: a case report from the FURI study
13 April 2019 - P0541
In vitro evaluation of biofilm disrupting agents against Candida auris and other Candida species
25 April 2017 - OS0846
A prospective, phase 2, multicentre, open-label, randomized, comparative study to estimate the safety, tolerability, pharmacokinetics, and efficacy of oral SCY-078 vs standard-of-care following initial intravenous echinocandin therapy in the treatment of
24 April 2017 - P1289
Clinical Outcomes in Adults with Complicated Urinary Tract Infections (cUTI), including Acute Pyelonephritis (AP) in TANGO 1, a Phase 3 Randomized, Double-blind, Double-dummy Trial Comparing Meropenem-Vaborbactam (M-V) with Piperacillin-Tazobactam (P-T)
26 April 2015 - O054
Infectious aetiology of community acquired pneumonia in paediatric hospitalized patients
Loading ...
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.